According to a clinical study report published in the annual meeting of the American Psychiatric Association, Vraylar is usually safe, well-tolerated and administered in the dosage approved by the Food and Drug Administration for patients who have bipolar disorders such as bipolar depression, bipolar mania and schizophrenia.
Consult our experts for free second medical opinion!